Bicycle Therapeutics SG&A Expense (Quarterly) Insights

Bicycle Therapeutics PLC (BCYC)

21.38 -0.80 (-3.63%) USD | NASDAQ | May 17, 16:00

21.38 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	16.45M
December 31, 2023	15.05M
September 30, 2023	15.57M
June 30, 2023	15.18M
March 31, 2023	14.04M
December 31, 2022	10.72M
September 30, 2022	10.25M
June 30, 2022	11.14M
March 31, 2022	16.85M
December 31, 2021	8.722M
September 30, 2021	8.268M
June 30, 2021	7.346M
March 31, 2021	8.096M

Date	Value
December 31, 2020	10.16M
September 30, 2020	6.406M
June 30, 2020	6.294M
March 31, 2020	4.998M
December 31, 2019	3.396M
September 30, 2019	4.789M
June 30, 2019	2.973M
March 31, 2019	3.402M
December 31, 2018	2.106M
September 30, 2018	2.325M
June 30, 2018	1.702M
March 31, 2018	1.988M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.973M

Minimum

Jun 2019

16.85M

Maximum

Mar 2022

9.834M

Average

9.440M

Median

SG&A Expense (Quarterly) Benchmarks